An equation to predict the changes in peak left ventricular pressure in hypertrophic obstructive cardiomyopathy after treatment: Application to the administration of disopyramide

Heart and Vessels

Volumn 14, Issue 2, 1999, Pages 72-81

  Niki, Kiyomi ^a   Sugawara, Motoaki ^a   Tanino, Shunsuke ^a   Iwade, Kazunori ^a   Hosoda, Saichi ^b   Kasanuki, Hiroshi ^a  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b SAKAKIBARA HEART INSTITUTE   (Japan)

Author keywords

Cardiomyopathy; Disopyramide; End systolic pressure volume relationship; Time varying elastance model

Indexed keywords

DISOPYRAMIDE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ELECTROCARDIOGRAM; FEMALE; HEART ATRIUM PACING; HEART CATHETERIZATION; HEART LEFT VENTRICLE PRESSURE; HEART OUTFLOW TRACT OBSTRUCTION; HEART RATE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; MALE; PRIORITY JOURNAL; R WAVE; SYSTOLIC BLOOD PRESSURE; VASCULAR RESISTANCE;

EID: 0033460143     PISSN: 09108327     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02481746     Document Type: Article

References (31)

1. Wigle ED, Rakowski H, Kimball BP, Williams WG (1995) Hypertrophic cardiomyopathy: clinical spectrum and treatment. Circulation 92:1680-1692
2. Bonow RO, Maron BJ, Leon MB, Cannon RO III, Epstein SE (1988) Medical and surgical therapy of hypertrophic cardiomyopathy. Cardiovasc Clin 19:221-239
3. Cannon RO III, Mclntosh CL, Schenke WH, Maron BJ, Bonow RO, Epstein SE (1989) Effect of surgical reduction of left ventricular outflow obstruction on hemodynamics, coronary flow, and myocardial metabolism in hypertrophic cardiomyopathy. Circulation 79:766-775
4. Pollick C, Rakowski H, Wigle ED (1984) Muscular subaortic stenosis: the quantitative relationship between systolic anterior motion and the pressure gradient. Circulation 69:43-49
5. Pollick C, Morgan CD, Gilbert BW, Rakowski H, Wigle ED (1982) Muscular subaortic stenosis: the temporal relationship between systolic anterior motion of the anterior mitral leaflet and the pressure gradient. Circulation 66: 1087-1094
6. Pollick C (1982) Muscular subaortic stenosis: hemodynamic and clinical improvement after disopyramide. N Engl J Med 307:997-999
7. Pollick C, Kimball B, Henderson M, Wigle ED (1988) Disopyramide in hypertrophic cardiomyopathy: I. Hemodynamic assessment after intravenous administration. Am J Cardiol 62:1248-1251
8. Duncan WJ, Tyrrell MJ, Bharadwaj BB (1991) Disopyramide as a negative inotrope in obstructive cardiomyopathy in children. Can J Cardiol 7:81-86
9. Kimball BP, Bui S, Wigle ED (1993) Acute dose-response effects of intravenous disopyramide in hypertrophic obstructive cardiomyopathy. Am Heart J 125:1691-1697
10. Niki K, Sugawara M, Asano R, Oka T, Kondoh Y, Tanino S, Iwade K, Magosaki N, Kasanuki H, Hosoda S (1997) Disopyramide improves the balance between myocardial oxygen supply and demand in patients with hypertrophic obstructive cardiomyopathy. Heart Vessels 12:111-118
11. Thompson DS, Naqvi N, Juul SM, Swanton RH, Coltart DJ, Jenkins BS, Webb-Peploe MM (1980) Effects of propranolol on myocardial oxygen consumption, substrate extraction, and haemodynamics in hypertrophic obstructive cardiomyopathy. Br Heart J 44:488-498
12. Suga H, Sagawa K, Shoukas AA (1973) Load independence of the instantaneous pressure-volume ratio of the canine left ventricle and effects of epinephrine and heart rate on the ratio. Circ Res 32:314-322
13. Suga H, Sagawa K, Demer L (1980) Determinants of instantaneous pressure in canine left ventricle: time and volume specification. Circ Res 46:256-263
14. Murgo JP, Alter BR, Dorethy JF, Altobelli SA, McGranahan GM Jr (1980) Dynamics of left ventricular ejection in obstructive and nonobstructive hypertrophic cardiomyopathy. J Clin Invest 66:1369-1382
15. Pak PH, Maughan WL, Baughman KL, Kass DA (1996) Marked discordance between dynamic and passive diastolic pressure-volume relations in idiopathic hypertrophic cardiomyopathy. Circulation 94:52-60
16. Stewart WJ, Schiavone WA, Salcedo EE, Lever HM, Cosgrove DM, Gill CC (1987) Intraoperative Doppler echocardiography in hypertrophic cardiomyopathy: correlations with the obstructive gradient. J Am Coll Cardiol 10:327-335
17. Maron BJ, Gottdiener JS, Arce J, Rosing DR, Wesley YE, Epstein SE (1985) Dynamic subaortic obstruction in hypertrophic cardiomyopathy: analysis by pulsed Doppler echocardiography. J Am Coll Cardiol 6:1-15
18. Wigle ED, Marquis Y, Auger P (1967) Muscular subaortic stenosis: initial left ventricular inflow tract pressure in the assessment of intraventricular pressure differences in man. Circulation 35:1100-1117
19. Hanya S (1989) Idiopathic hypertrophic subaortic stenosis: analysis using a multisensor catheter. In: Sugawara M, Kajiya F, Kitabatake A, Matsuo H (eds) Blood flow in the heart and large vessels. Springer, Berlin Heidelberg New York Tokyo, pp 120-123
20. Pierce GE, Morrow AG, Braunwald E (1964) Idiopathic hypertrophic subaortic stenosis: III. Intraoperative studies of the mechanism of obstruction and its hemodynamic consequences. Circulation 30 (suppl 4):152-213
21. Brutsaert DL, Sys SU (1989) Relaxation and diastole of the heart. Physiol Rev 69:1228-1315
22. Glantz SA, Slinker BK (1990) Primer of applied regression and analysis of variance. McGraw-Hill, New York, pp 35-36
23. Harrison DC, Braunwald E, Glick G, Mason DT, Chidsey CA, Ross J Jr (1964) Effects of beta adrenergic blockade on the circulation, with particular reference to observations in patients with hypertrophic subaortic stenosis. Circulation 29:84-98
24. Millaire A, Goullard L, Decoulx E, deGroote P, Houdas Y, Ducloux G (1992) Efficiency of disopyramide in hypertrophic cardiomyopathy during stress states. Am J Cardiol 69:423-424
25. Kass DA, Maughan WL, Guo ZM, Kono A, Sunagawa K, Sagawa K (1987) Comparative influence of load versus inotropic status on indexes of ventricular contractility: experimental and theoretical analysis based on pressurevolume relationships. Circulation 76:1422-1436
26. Naqvi N, Thompson DS, Morgan WE, Williams BT, Coltart DJ (1979) Haemodynamic effects of disopyramide in patients after open-heart surgery. Br Heart J 42:587-594
27. Koetter V, Linderer T, Schroeder R (1980) Effects of disopyramide on systemic and coronary hemodynamics and myocardial metabolism in patients with coronary artery disease: comparison with lidocaine. Am J Cardiol 46:469-475
28. McDonald K, McWilliams E, O'Keeffe B, Maurer B (1988) Functional assessment of patients treated with permanent dual chamber pacing as a primary treatment for hypertrophic cardiomyopathy. Eur Heart J 9:893-898
29. Jeanrenaud X, Goy JJ, Kappenberger L (1992) Effects of dual-chamber pacing in hypertrophic obstructive cardiomyopathy. Lancet 339:1318-1323
30. Endresen K, Amlie JP, Forfang K (1988) Effects of disopyramide on repolarisation and interventricular conduction in man. Eur J Clin Pharmacol 35:467-474
31. Lee JK, Takanaka C, Nonokawa M, Kato H, Yabe S, Kodama I, Toyama J (1995) Complex frequency-dependent interaction of class-I antiarrhythmic drugs as they affect intraventricular conduction. Eur Hear J 16:832-841